BioDirection, Inc. Selected to Present at Cavendish Global Health Impact Forum

Forum uniquely brings together leading family offices and their foundations seeking impact investment, grant-giving, and philanthropy opportunities within health and life sciences

April 15, 2015

Boston, MA – April 15 2015 – an emerging medical device company focused on the development and commercialization of rapid, affordable point-of-care devices for the early identification of mild traumatic brain injury (concussion), announced today it has been selected to present at the Cavendish Global Health Impact Forum taking place May 10th to May 14th in La Jolla, California. The purpose of the Forum is to help family offices and foundations develop and implement their individual pro-social impact investing, grant-giving, and philanthropy programs within health and the life sciences. To accomplish this mission, the Forum showcases presentations and panel discussions by leading research institutions, accomplished healthcare delivery professionals, health-policy experts and private-sector companies engaged in developing innovations with the potential for transformational impact on disease prevention, diagnosis and treatment. A unique gathering of leading family offices, Cavendish Impact Forums are hosted by leading institutions around the world and take place three times each year. The next Forum is being co-hosted by the community of La Jolla, California including The University of California San Diego, The J. Craig Venter Institute, The Scripps Research Institute, The Sanford-Burnham Medical Research Institute, The Sanford Consortium for Regenerative Medicine, and The Institute of the Americas.

Michael Moffat, Cavendish co-founder and Chief Executive Officer explains, “The theme of our La Jolla, California Forum is a ‘Celebration of Philanthropy, Impact Investing and Innovation that is Changing the World.’ With the help of our expert advisors, we conduct a global search of research institutions and private-sector companies in order to identify organizations that meet the required standard of excellence. The quality and originality of BioDirection’s research and scientific insights in the application of bio nano technology positions them to make a major contribution to the diagnosis of brain trauma.”

“We are honored to be selected to present at this unique event, and it is further recognition of our innovative approach to address the global unmet need for early, simple and accurate detection of concussion which impacts all ages, occupations and lifestyles.” said James A. Wylie, Executive Chairman. “We welcome the chance to interact with many of world’s most accomplished scientists, thought-leaders and generous philanthropic individuals and families who are all dedicated to the common cause of improving the health and lives of people around the world.”

Cavendish Global consists of leading family offices and foundations from around the world with combined assets of over $190 billion who share a passion for pro-social endeavors within health and the life sciences. The Cavendish Global Health Impact Forum provides family offices with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the information and educational resources required by foundations actively seeking to accelerate technological innovation and health access through sustainable philanthropy, grant-making and impact investing. The Forum is also an opportunity for family offices to champion and share information on projects and organizations, which they are passionate about with other family offices from around the world.

About BioDirection

BioDirection, Inc. is a privately-held medical device company focused on the design, development and commercialization of easy-to-use, affordable and portable devices for the screening and monitoring of acquired brain injury. The company’s strategy is to blend proven clinical science with innovative technology to create diagnostic tools that address critical market needs. BioDirection’s platform technology has the potential to become the standard of care for the objective diagnosis, prognosis and status of acquired brain injuries.

Further information is available on the Company’s website: http://www.biodirection.com

Contacts
BioDirection, Inc.

James Wylie, Executive Chairman
Tel: +1 (203) 240-1319
Email: jwylie@biodirection.com

Eric Goorno, President & CEO
Tel: +1 (508) 308-8592
Email: egoorno@biodirection.com

About Cavendish Global

Cavendish Global provides family offices and their foundations with a discrete, peer-to-peer knowledge expansion and relationship building environment, combined with the innovative resources required to help develop and implement their individual pro-social impact investment and philanthropy programs within health and the life sciences. Cavendish Global provides family offices with a number of innovative resources, which includes Cavendish Impact Forums. A unique gathering of leading family offices, Cavendish Impact Forums take place three times each year; the next Forum is being co-hosted at leading research institutions of the community of La Jolla, California including The University of California San Diego, The J. Craig Venter Institute, The Scripps Research Institute, The Sanford-Burnham Medical Research Institute, The Sanford Consortium for Regenerative Medicine, and The Institute of the Americas.

For more information: http://cavendishglobal.com

Contacts
Cavendish Global

Alex Charlton, President
Tel: +1-917-576-1435
Email: alex.charlton@cavendishglobal.com

BioDirection is always searching for new opportunities. Contact us today with any questions or inquiries.